Table: Fuji Pharmaceutical -2018/19 group results

Fuji Pharma

08/11/2019 08:00

Nov 8 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2019    Sep 30, 2018   Sep 30, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           36.28           37.91          33.83        16.65    
               (-4.3 pct)      (+7.1 pct)     (-6.8 pct)    (-9.9 pct) 
  Operating        4.17            4.39           2.57         1.21    
               (-5.0 pct)      (+1.8 pct)     (-38.4 pct)  (-51.0 pct) 
  Recurring        4.17            4.47           2.50         1.17    
               (-6.8 pct)      (-3.4 pct)     (-40.0 pct)  (-53.1 pct) 
  Net
  Net              2.96            3.37           1.66       781 mln   
               (-12.2 pct)     (+2.2 pct)     (-43.8 pct)  (-53.9 pct) 
  EPS           97.04 yen      112.68 yen      53.44 yen    25.09 yen  
  Ann Div       29.00 yen                      29.00 yen               
  -Q2 Div       14.00 yen       28.00 yen      14.00 yen               
  -Q4 Div       15.00 yen       14.00 yen      15.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T